Shandong Buchang Pharmaceuticals Co., Ltd. (SHA: 603858) announced today a comprehensive licensing agreement with fellow...
Bayer AG (ETR: BAYN) announced today that the U.S. Food and Drug Administration (FDA) has...
UCB (EBR: UCB) announced today Week 16 data from the BE BOLD Phase III clinical...
United Laboratories International Holdings Ltd (HKG: 3933) announced today it has received tacit approval from...
ImmuneOnco Biopharmaceuticals (Shanghai) Co., Ltd. (HKG: 1541) announced today the dosing of the first patient...
Bio-Thera Solutions (SHA: 688177) announced it has received marketing approval from the U.S. Food and...
GlaxoSmithKline plc (GSK) (NYSE: GSK) has restructured its vaccine business operations in China, splitting the...
Boston Scientific Corporation (NYSE: BSX) announced a strategic $1.5 billion investment for an approximately 34%...
Shanghai Henlius Biotech, Inc. (HKG: 2696) announced a strategic partnership with fellow Chinese biopharmaceutical company...
Lundbeck (OTCMKTS: HLUBF) announced that Japan’s Ministry of Health, Labour and Welfare (MHLW) has granted...
Nanjing Leads Biolabs Co., Ltd. (HKG: 9887) announced it has received regulatory clearance in China...
CSPC Pharmaceutical Group Ltd. (HKG: 1093) announced it has received clinical trial approval from China’s...
Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) announced a strategic research collaboration with Parabilis Medicines to discover...
Boehringer Ingelheim (BI) announced that Japan’s Ministry of Health, Labour and Welfare (MHLW) has granted...
Bayer AG (ETR: BAYN) announced that the U.S. Food and Drug Administration (FDA) has granted...
Zhejiang Shimai Pharmaceutical Co., Ltd., a T-cell engager (TCE) specialist founded in 2017, has filed...
Suzhou Sanegene Bio Inc., an RNAi specialist with R&D centers in the U.S. and China,...
Youcare Pharmaceutical Group (SHA: 688658) announced a RMB 1 billion ($147 million) investment to establish...
Jiangsu Hengrui Pharmaceuticals Co., Ltd. (SHA: 600276, HKG: 1276) announced that the Phase III SHR-A2009-301...
BrightGene (Suzhou) Bio-Medical Technology Co., Ltd. (SHA: 688166) has filed its prospectus with the Hong...